跳至主要内容
临床试验/ITMCTR2000003703
ITMCTR2000003703
尚未招募
1 期

A clinical study on the Regulation of Intestinal Microenvironment in coIX Lachana Fujiang Powder for the prevention and Treatment of malignant neoplasia in advanced colorectal adenoma

Shuguang Hospital affillated with Shanghai University of TCM0 个研究点待定

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
Shuguang Hospital affillated with Shanghai University of TCM
状态
尚未招募
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
3年前
研究类型
Interventional study
性别
All

研究者

发起方
Shuguang Hospital affillated with Shanghai University of TCM

入排标准

入选标准

  • 1\. Progressive colonic adenoma with clear pathological diagnosis refers to adenoma with \> 25% villous structure diameter \>\=10 mm or adenoma with high\-grade intraepithelial neoplasia, which meets one of the above conditions;
  • 2\. Aged between 18 and 75 years;
  • 3\. The TCM syndrome type conforms to the syndrome of dampness accumulation of spleen deficiency and stagnation of blood stasis and heat, and is intended to be treated with TCM;
  • 4\. Did not take antibiotics, aspirin, immunosuppressants and other drugs within three months;
  • 5\. no serious heart, liver, kidney, hematopoietic system diseases or other factors affecting drug evaluation;
  • 6\. The diet is relatively stable, can complete the questionnaire, and voluntarily sign the informed consent.

排除标准

  • 1\. Patients with digestive tract diseases, metabolic diseases, cardiovascular diseases, liver diseases, neurological diseases and autoimmune diseases;
  • 2\. Take yogurt or probiotics regularly for a long time (2\-3 times per week, more than 6 months);
  • 3\. Pregnant and lactating women;
  • 4\. Allergic to certain drugs in the prescription of Chinese medicine;
  • 5\. Have joined other clinical researchers;
  • 6\. The researcher considers it inappropriate to participate in the study.

结局指标

主要结局

未指定

相似试验